TY  - RPRT
TI  - Multitargeted comparative evaluation suggests 2-Aoeobenoxmide shows favourable in silico binding compared to Tucatinib against ERα, HER2, AKT1, EGFR, and PIK3CA in breast cancer.
AU  - Mohammed H Al-Qahtani
AU  - Mohammad Alam Jafri
AU  - Mourad Assidi
AU  - Abdelbaset Buhmeida
AU  - Peter Natesan Pushparaj
AU  - Maha Khalid Abdullah
AU  - Nofe Ateq Alganmi
PY  - 2026
DO  - 10.1038/s41598-026-57604-0
UR  - https://pubmed.ncbi.nlm.nih.gov/42310133/
ID  - 42310133
ER  -